Diagnostics & Precision Medicine

Precision medicine is hailed as a new revolution in health care and with good reason. The ability to gather information about an individual patient and to tailor a customised treatment accordingly marks a paradigm shift in the way that medicine is carried out.

We work with innovators in sequencing, genomics, proteomics, metabolomics and cell biology, as well as bioinformatics, biosensors and artificial intelligence, all of which play a part in this exciting field of precision medicine.

Our expertise and experience extend across the whole range of precision medicine and diagnostics technologies, from medical devices and wearables, through to biomarker discovery, liquid biopsy, and bioinformatics. Developments in this area are often multidisciplinary, drawing on advances in biology, engineering and computer science, and this is reflected in our team of expert attorneys, drawn from across specialisms, who collaborate to bring together knowledge and experience to develop effective IP strategies for new technologies in this rapidly developing space.

We’re experts in protecting precision medicine inventions at the European Patent Office. We’ve helped to shape the case law in this precision medicine, helping clients with new ideas in personalised medicine to protect their next generation therapeutics and we have an enviable track record in securing granted patents for seemingly difficult-to-patent inventions in bioinformatics.

We’re also well versed in the challenges of protecting precision medicine technologies around the world, helping clients to draft applications that can be used to protect inventions in different jurisdictions.  This takes account of the different approaches that different patent offices have to precision mention inventions, and also reflecting the clinical and commercial reality of these technologies which may involve multiple parties undertaking different parts of the process, sometimes in different countries.

Find out more on our Precision Medicine spotlight page.

Find out more about protecting your innovations

Pink-Pentagons-HQ

Bioinformatics & Digital Health

Pink-Pentagons-HQ

Liquid Biopsy

Pink-Pentagons-HQ

Medical Devices & Sensors

Pink-Pentagons-HQ

Precision Medicine & Biomarkers

Patent_Landscape_in_Bioinformatics_and_Digital_Health_Special_Report_2021-2-Compressed

Special Report

Patent Landscape in Bioinformatics and Digital Health: a data-driven analysis

The words "digital health", "data driven" and "AI" have been on everyone's lips and in many headlines in the healthcare and life sciences sectors over the last couple of years. We set out to collect data on the patent landscape in the fields of bioinformatics and digital health, to see whether the growth we and our clients see in the field is reflected in the data and whether insights can be gained that will assist in designing better, more informed IP strategies.

Read our Blogs

Endometriosis - research, diagnosis and treatment progress

Endometriosis - research, diagnosis and treatment progress

by Fay Allen

March is Endometriosis Action Month, and this year’s focus is on raising awareness.

Cancer-killing bacteria: past, present and future

Cancer-killing bacteria: past, present and future

by Edward Couchman

While bacteria have frequently made the medical news in recent years due to the urgent problem of antibiotic resistance, there is a growing movement trying to harness their capabilities for medical ...

Yoni Health: the medical secrets of menstrual blood

Yoni Health: the medical secrets of menstrual blood

by Frances Salisbury

Menstrual effluent contains a wealth of scientific info, including biomarkers for endometriosis, diabetes, certain cancers and polycystic ovary syndrome. Yoni Health is the first start-up in this ...

Gene sequencing accelerates with custom hardware

Gene sequencing accelerates with custom hardware

by Alex Burns

The cost to sequence a genome continues to drop exponentially. Over the past 20 years, the cost to sequence a human genome has dropped from the estimated $3 billion of the Human Genome Project, to a ...

Replacing the bad with the good – an IP perspective on microbial consortia

Replacing the bad with the good – an IP perspective on microbial consortia

by Ine Vanderleyden

Our body hosts trillions of microorganisms that are essential to many aspects of human health. This constellation of microorganisms is referred to as the ‘microbiome’. Scientists are only beginning ...

Exosomes in liquid biopsy: a nanometric particle packed with potential

Exosomes in liquid biopsy: a nanometric particle packed with potential

by Alice Jefferies

We are all too familiar with the statistic that 1 in 2 of us will get cancer in our lifetime. Of that, just under 50% of cancer diagnoses were at stage 3 or 4 in England in 2018, highlighting the ...

We work at every stage of the IP lifecycle

Protect

Drafting, Filing & Prosecution
Portfolio Management
Searching & Watching
Renewals & EP Validations

Defend

Pre-action Advice
Oppositions & Appeals
Litigation
Alternative Dispute Resolution

Exploit

Strategic Advice
Commercial Issues
Transactions
Corporate Support

Forward Magazines Overlapping 8

Mewburn Ellis

FORWARD MAGAZINE

Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.